Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

被引：0
|
作者：
P L Nguyen
N E Martin
V Choeurng
B Palmer-Aronsten
T Kolisnik
C J Beard
P F Orio
M D Nezolosky
Y-W Chen
H Shin
E Davicioni
F Y Feng
机构：
[1] Dana-Farber/Brigham and Women’s Cancer Center and Harvard Medical School,Department of Radiation Oncology
[2] GenomeDx Biosciences,Department of Radiation Oncology
[3] University of California at San Francisco,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2017年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：186 / 192
页数：6
相关论文
共 50 条
  • [21] Biopsy-based basal-luminal subtyping classifier in high-risk prostate cancer: Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 randomized phase III trials
    Nguyen, P.
    Liu, V.
    Proudfoot, J. A.
    Davicioni, E.
    Liu, Y.
    Dal Pra, A.
    Spratt, D. E.
    Sandler, H. M.
    Efstathiou, J. A.
    Lawton, C.
    Simko, J. P.
    Rosenthal, S.
    Zeitzer, K.
    Mendez, L.
    Hartford, A.
    Hall, W.
    Desai, A.
    Pugh, S.
    Tran, P. T.
    Feng, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1172 - S1173
  • [22] Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience
    Pedone, Cristiana
    Sorcini, Bruno
    Staff, Caroline
    Farlin, Johanna
    Fokstuen, Tone
    Frodin, Jan-Erik
    Nilsson, Per J.
    Martling, Anna
    Valdman, Alexander
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 39
  • [23] VALIDATION OF A GENOMIC CLASSIFIER FOR PREDICTING CLINICAL PROGRESSION FOLLOWING POST-OPERATIVE RADIATION THERAPY IN HIGH-RISK PROSTATE CANCER
    Trabulsi, Edouard
    Karnes, Jeffrey
    Feng, Felix
    Showalter, Timothy
    Mishra, Mark
    Lallas, Costas
    Gomella, Leonard
    Birbe, Ruth
    McCue, Peter
    Ghadessi, Mercedeh
    Buerki, Christine
    Davicioni, Elai
    Knudsen, Karen
    Dicker, Adam
    Den, Robert
    JOURNAL OF UROLOGY, 2014, 191 (04): : E930 - E930
  • [24] Validation of a 22-gene Genomic Classifier in the NRG Oncology/RTOG 9202, 9413 and 9902 Phase III Randomized Trials: A Biopsy-Based Individual Patient Meta-Analysis in High-Risk Prostate Cancer
    Nguyen, P. L.
    Huang, H. C.
    Davicioni, E.
    Sandler, H. M.
    Shipley, W. U.
    Efstathiou, J. A.
    Simko, J.
    Pollack, A.
    Dicker, A. P.
    Roach, M.
    Rosenthal, S. A.
    Morginstin, M.
    Mendez, L.
    Hartford, A. C.
    Hall, W. A.
    Desai, A. B.
    Rabinovitch, R.
    Peters, C. A.
    Rodgers, J.
    Feng, F. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S50 - S50
  • [25] Utilization of 17-gene biopsy-based genomics scores in treatment decisions for low- to intermediate-risk patients with prostate cancer.
    Katz, Aaron
    Mulcahy, Megan
    Rice, Jacquelyn
    Kosinski, Kaitlin E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [26] Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT
    Zeina Ayoub
    Jamal Khader
    Muhammad Bulbul
    Raja B. Khauli
    Therese Y. Andraos
    Ali Shamseddine
    Deborah Mukherji
    Fady B. Geara
    BMC Urology, 22
  • [27] Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy
    Morgan, Peter B.
    Hanlon, Alexandra L.
    Horwitz, Eric M.
    Buyyounouski, Mark K.
    Uzzo, Robert G.
    Pollack, Alan
    CANCER, 2007, 110 (01) : 68 - 80
  • [28] Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT
    Ayoub, Zeina
    Khader, Jamal
    Bulbul, Muhammad
    Khauli, Raja B. B.
    Andraos, Therese Y. Y.
    Shamseddine, Ali
    Mukherji, Deborah
    Geara, Fady B. B.
    BMC UROLOGY, 2022, 22 (01)
  • [29] Two Year Outcomes of Short-Term Potent Androgen Blockade and Definitive Radiation for Intermediate to High Risk Localized Prostate Cancer
    Koontz, B. F.
    Hoffman, K. E.
    Healy, P.
    George, D. J.
    Harrison, M. R.
    Zhang, T.
    Lee, W. R.
    Berry, W. R.
    Pugh, T. J.
    Bratt, L.
    Hobbs, B.
    Halabi, S.
    Corn, P. G.
    Armstrong, A.
    Shobe, K.
    Tojong, B.
    Thornburg, B.
    Brummer, K.
    Allen, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S100 - S100
  • [30] Utilization of a Novel Adaptive Dose Recalculation Tool in the Delivery of High-Dose Radiation for Intermediate- to High-Risk Prostate Cancer
    Edwards-Bennett, S. M.
    Herbert, A. J.
    Key, S. M.
    Andrews, S. F.
    Francke, P. M.
    Barton, R. A.
    Swist, J. D.
    Hodges, C. B.
    Walls, R. L.
    Root, W.
    Mahan, S. L.
    Mantz, C. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S877 - S878
12345